Skip to main content
Premium Trial:

Request an Annual Quote

NCI Extends License for Partek Genomics Suite

NEW YORK (GenomeWeb News) - The National Cancer Institute has renewed its site license for Partek’s Genomics Suite software, Partek said today.
 
NCI initially licensed the statistical and visual analysis package last September.
 
The software may be used to display alternative splice events, exon-level and copy number alteration, mapping sites of protein and DNA interaction, and has import and annotation capabilities for two-color arrays, Partek said.
 
Financial terms of the agreement were not released.
The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.